STREFEN |
U-27182 |
BTS-18322 |
ANSAID |
FROBEN |
BTS 18322 |
FLURBIPROFEN |
TRANSACT |
FLUBIPROFEN |
CEBUTID |
FROBEN SR |
OCUFEN |
FLURBIPROFENO |
2-(2-FLUOROBIPHENYL-4-YL)PROPANOIC ACID |
ANSAID® |
FLURBIPROFENE |
(+-)-2-FLUORO-ALPHA-METHYL-4-BIPHENYLACETIC ACID |
2-FLUORO-ALPHA-METHYL-(1,1'-BIPHENYL)-4-ACETIC ACID |
FLURBIPROFENUM |
3-FLUORO-4-PHENYLHYDRATROPIC ACID |
FLP |
S-FLURBIPROFEN |
FROBEN® |
rxcui:4502 |
drugbank:00712 |
chemidplus:5104-49-4 |
pubchem.compound:3394 |
chembl:CHEMBL563 |
Drug Class | anti-inflammatory agents, non-steroidal |
Year of Approval | 1986 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antiinflammatory agent,NSAID |
Drug Categories | agents causing hyperkalemia |
Drug Categories | agents that produce hypertension |
Drug Categories | anti-inflammatory agents, non-steroidal (non-selective) |
Drug Categories | antiinflammatory and antirheumatic products |
Drug Categories | antiinflammatory and antirheumatic products, non-steroids |
Drug Categories | antiinflammatory preparations, non-steroids for topical use |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | musculo-skeletal system |
Drug Categories | nephrotoxic agents |
Drug Categories | non cox-2 selective nsaids |
Drug Categories | oat1/slc22a6 inhibitors |
Drug Categories | other nonsteroidal anti-inflammatory agents |
Drug Categories | photosensitizing agents |
Drug Categories | throat preparations |
Drug Categories | topical products for joint and muscular pain |
Drug Categories | ugt1a1 inhibitors |
Drug Categories | ugt1a1 substrates |
Drug Categories | ugt1a3 substrates |
Drug Categories | ugt1a9 substrates |
Drug Categories | ugt2b7 substrates |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | HCT 1026, NO-flurbiprofen |
Mechanism of Interaction | Cyclooxygenase inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclooxygenase inhibitor |
Direct Interaction | yes |
Specific Action of the Ligand | Inhibition |
5104-49-4 | CAS Number |
Acustop Cataplasma | Drug Brand |
Adofeed | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
Year of Approval | 1986 |
Drug Class | anti-inflammatory agents, non-steroidal |
Drug Indications | antiinflammatory agent,NSAID |
Drug Class | Small Molecule |
FDA Approval | approved |
C508 | NCI drug code |
CHEMBL563 | ChEMBL Drug ID |
D0A1PX | TTD Drug ID |